Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Long-Term Morbidity Following Axillary Dissection in Breast Cancer Patients – Clinical Assessment, Significance for Life Quality and the Impact of Demographic, Oncologic and Therapeutic Factors

  • 234 Accesses

  • 140 Citations

Abstract

Objective. This study describes in detail the surgery-related symptoms following axillary lymph node dissection in breast cancer patients and considers both their significance for long term quality of life and the impact of possible influencing factors.

Material and methods: Three hundred and ninety six patients were studied retrospectively using a self-report questionnaire and a clinical examination. The symptoms, numbness, pain, edema, arm strength and mobility were evaluated. The subjective assessment of the degree of symptom intensity was compared with objective measurements. The extent of surgery (number of resected nodes, level of dissection) as well as the influence of demographic, oncologic and adjuvant measures (age, time interval, number of involved nodes, chemotherapy) were evaluated.

Results. Shoulder-arm morbidity and fear of cancer recurrence were the most important long-term sources of distress following breast cancer surgery in our study population. Demographic, oncologic and therapeutic measures including the extent of surgery had no influence on long-term morbidity. The intensity of all evaluated symptoms was reported to be more severe in patients' subjective statements than in the results of clinical assessment.

Conclusion. Shoulder-arm morbidity following axillary dissection is a frustrating polysymptomatic disease that seems to be relatively unaffected by therapeutic measures. The surgical trauma necessary for adequate tumor staging (removal of 10 lymph nodes) seems decisive for the postsurgery syndrome following axillary dissection. For node-positive patients complete axillary clearing may improve tumor control without worsening long-term-morbidity. New techniques, such as the sentinel-node-biopsy, that selects patients with negative axillary status while preserving the integrity of axillary structures, may improve the overall morbidity.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Moffat FL, Jr., Senofsky GM, Davis K, Clark KC, Robinson DS, Ketcham AS: Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 51(1): 8-13, 1992

  2. 2.

    Moore MP, Kinne DW: Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes. Important Adv Oncol 245-250, 1996

  3. 3.

    Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival — a Bayesian meta-analysis. Ann Surg Oncol 6(1): 17-18, 1999

  4. 4.

    Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312(11): 674-681, 1985

  5. 5.

    Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P: Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 73(3): 664-667, 1994

  6. 6.

    Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME: Axillary lymph node dissection: is it required in T1a breast cancer? J Am Coll Surg 184(5): 493-498, 1997

  7. 7.

    Xianglin D, Freeman JL, Goodwin S: The declining use of axillary dissection in patients with early stage breast cancer. Breast Cancer Res Treat 53(2): 137-144, 1999

  8. 8.

    Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D: Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 50(6): 445-449, 1993

  9. 9.

    Maunsell E, Brisson J, Deschenes L: Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36: 315-320, 1993

  10. 10.

    Hack TF, Cohen L, Katz J, Robson L, Goss P: Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17: 143-149, 1999

  11. 11.

    Mathiesen O, Carl J, Bonderup O, Panduro J: Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol 29(6): 721-725, 1990

  12. 12.

    Suzanne F, Emering C, Wattiez A, Bournazeau JA, Bruhat MA, Jaquetin B: Axillary lymphadenectomy by lipoaspiration and endoscopic picking. A propos of 72 cases. Chirurgie 122: 138-142, 1997

  13. 13.

    Kamprath S, Bechler J, Kuhne-Heid R, Krause N, Schneider A: Endoscopic axillary lymphadenectomy without prior liposuction. Development of a technique and initial experience. Surg Endosc 13(12): 1226-1229, 1999

  14. 14.

    Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220(3): 391-398, 1994

  15. 15.

    Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2(6): 335-339, 1993

  16. 16.

    Krag D, Weaver DL, Ashikaga T, Moffat F, Klimberg S, Shriver C, Felman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer. A multicenter validation study. New Eng J Med 339(14): 941-946, 1998

  17. 17.

    Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349(9069): 1864-1867, 1997

  18. 18.

    Noguchi M, Tsugawa K, Bando E, Kawahara F, Miwa K, Yokoyama K, Nakajima K, Tonami N: Sentinel-lymphadenectomy in breast cancer: identification of sentinel-lymph node and detection of metastases. Breast Cancer Res Treat 53(2): 97-104, 1999

  19. 19.

    Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J: Complications of Level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 230(2): 194-201, 1999

  20. 20.

    Brismar B, Ljungdahl I: Postoperative lymphoedema after treatment of breast cancer: Acta Chir Scand 149: 687-689, 1983

  21. 21.

    Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B, Silen W, Harris JR: Edema of the arm as a function of the extent of axillary surgery in patients with stage I–II carcinoma of the breast treated with primary radiotherapy. Int J Radiol Oncol Biol Phys 12: 1575-1582, 1986

  22. 22.

    Liljegren G, Holmberg L: Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer 33(2): 193-199, 1997

  23. 23.

    Tasmuth T, von Smitten K, Kalso E: Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 74: 2024-2031, 1996

  24. 24.

    Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT: Assessment of morbidity from complete axillary dissection. Br J Cancer 66: 136-138, 1992

  25. 25.

    Kuhnke E: Determination of volume by measuring the circumferences. Folia Angiol 24: 228-232, 1976

  26. 26.

    Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B: Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol 16(2): 487-494, 1998

  27. 27.

    Tobin MB, Psych MRC, Lacey HJ, Psych FRC, Meyer L, Mortimer PS: The psychological morbidity of breast cancer-related swelling. Cancer 72: 3248-3252, 1993

  28. 28.

    White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI: Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 183(6): 575-582, 1996

  29. 29.

    Sosa JA, Diener-West M, Gusev Y, Choti MA, Lange JR, Dooley D, Zeiger M: Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol 5(2): 140-149

  30. 30.

    Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Tria. N Engl J Med 337(14): 949-955, 1997

  31. 31.

    Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Coldman AJ, Olivotto IA: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337(14): 956-962, 1997

  32. 32.

    Tate JJT, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I: Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 15: 271-276, 1998

  33. 33.

    De Freitas R, Costa V, Schneider RV, Nicolau MA, Mrussi E: Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 17: 240-244, 1991

  34. 34.

    Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M: Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-/flurine-18-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst 88: 1204-1209, 1996

  35. 35.

    Fowble B, Solin LJ, Schutz DJ: Frequency, sites of relapse and outcome of regional node failure following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 17: 703-710, 1989

  36. 36.

    Recht A, Pierce SM, Abner A: Regional nodal failure after conservative surgery and radiotherapy for early stage breast cancer. J Clin Oncol 9: 988-996, 1991

  37. 37.

    Christensen SB, Lundgren E: Sequelae of axillary dissection versus axillary sampling with or without irradiation for breast cancer. Acta Chir Scand 155: 515-520, 1989

  38. 38.

    Constant CR, Murley AHG: A clinical method of function assessment of the shoulder. Clin Ortop 214: 160-164, 1985

  39. 39.

    Aitken RJ, Gaze MN, Rodger A, Chetty U, Forrest APM: Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance. Br J Surg 76(6): 568-571

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kuehn, T., Klauss, W., Darsow, M. et al. Long-Term Morbidity Following Axillary Dissection in Breast Cancer Patients – Clinical Assessment, Significance for Life Quality and the Impact of Demographic, Oncologic and Therapeutic Factors. Breast Cancer Res Treat 64, 275–286 (2000). https://doi.org/10.1023/A:1026564723698

Download citation

  • axillary dissection
  • breast cancer
  • morbidity
  • quality of life